| Anti-inflammatory therapy for diabetic retinopathy. | |
| | |
MedLine Citation:
|
PMID: 21554091 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Diabetic retinopathy (DR) is one of the most common complications of diabetes. This devastating disease is a leading cause of blindness in people of working age in industrialized countries and affects the daily lives of millions of people. Despite tight glycemic control, blood pressure control and lipid-lowering therapy, the number of DR patients keeps growing and therapeutic approaches are limited. Moreover, there are significant limitations and side effects associated with the current therapies. Thus, there is a great need for development of new strategies for prevention and treatment of DR. Studies have shown that DR has prominent features of chronic, subclinical inflammation. This article focuses on the role of inflammation in DR and summarizes the progress of studies of anti-inflammatory strategies for DR. |
| | |
Authors:
|
Wenbo Zhang; Hua Liu; Modesto Rojas; Robert W Caldwell; Ruth B Caldwell |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Immunotherapy Volume: 3 ISSN: 1750-7448 ISO Abbreviation: Immunotherapy Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101485158 Medline TA: Immunotherapy Country: England |
Other Details:
|
Languages: eng Pagination: 609-28 Citation Subset: IM |
Affiliation:
|
Vascular Biology Center, Georgia Health Sciences University, Augusta, GA, 30912-2500, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: mRNA: delivering an antitumor message?
Next Document: One century of allergen-specific immunotherapy for respiratory allergy.